Letters to our LPs
We prioritize transparency by providing insight into our strategies and decisions. Explore our latest LP updates on investment progress.
New Exciting Updates from D3VC – A Book, A Report, and More!Post
At D3VC, we’ve been busy with our weekly diligence meetings, and we’re excited to share that we’ve made several new investments. I’ll provide more details on those in an upcoming update. In the meantime, I wanted to share two exciting developments with you: Read more ...
D3VC: New Investments, Major Wins & What's Ahead
Since our last update, D3VC has made meaningful progress on both our portfolio and our platform. We’ve recently added five standout companies across digital health, consumer products, climate tech, and fintech—each sourced and scored by our AI-powered diligence engine. Read more ...
D3VC Investment Update: Three New Investments, Policy Proposal, Speaking Engagement
We are thrilled to provide you with an update on our latest activities at D3VC. Over the past month, we made three strategic investments, further expanding our portfolio in the hospitality, crowdfunding, and sports sectors. Below are the details of the companies we've added to our growing list of investments. Other than scoring high on our algorithm, these companies showcase how we are diversifying within the space. Read more ...
D3VC August Investment Update: Deverra Therapeutics & EarthGrid
We are excited to share that D3VC has made two strategic investments in August, further expanding our portfolio in the healthcare and energy sectors. Below are the details of the companies we have added to our growing list of investments: 1. Deverra Therapeutics - Industry: Healthcare, Biotechnology, and Life Sciences. Website: deverratx.com. Deverra Therapeutics is at the forefront of revolutionizing immune cell therapies for cancer and other life-threatening illnesses. Read more ....
Exciting News: D3VC Goes Live and Announces First Investments!
I am thrilled to share some exciting updates with you. D3VC has officially gone live, and we have successfully made our first three investments in Corvion, Target Arm, and Sweater. These investments mark a significant milestone for us and highlight the diverse and innovative companies we are supporting. Corvion is a medical technology company developing a revolutionary Left Ventricular Assist Device (LVAD) to improve the quality of life for patients with end-stage Read more ...
Exciting Updates from D3VC: Fund Countersigning, Capital Deployment, and Upcoming Events
Thank you for your patience and diligence in reviewing the fund documents. We're thrilled to announce that we will begin countersigning on June 19th, with our capital call following shortly after. This marks the start of our journey to deploy capital into some of the most promising startups in the industry! As we move forward with our weekly investment decisions, I'll make sure to update you regularly. You'll also receive our research reports to stay abreast of industry developments. Read more ...
D3VC Update - Increased Deal flow, Podcast, & Crowdfunding Genome Announcement
We've been busy at D3VC. A few trends are happening in the private capital markets that are proving to be positive for us. According to Pitchbook and our friends on Sand Hill Road, VCs are still sitting on the sidelines with signals that they won't start to invest until later in the year. This means more companies are turning online for capital, and hence, we are seeing an increase in deal flow and investor interest. We are also seeing a drop in valuations, mainly in the pre-revenue Read more ...